201 related articles for article (PubMed ID: 22593646)
1. Metabolic enzyme considerations in cancer therapy.
Jain AK; Jain S; Rana AC
Malays J Med Sci; 2007 Jan; 14(1):10-7. PubMed ID: 22593646
[TBL] [Abstract][Full Text] [Related]
2. Regulation of phase II biotransformation enzymes by steroid hormones.
Kohalmy K; Vrzal R
Curr Drug Metab; 2011 Feb; 12(2):104-23. PubMed ID: 21401512
[TBL] [Abstract][Full Text] [Related]
3. Drug-metabolizing enzymes: role in drug resistance in cancer.
Kaur G; Gupta SK; Singh P; Ali V; Kumar V; Verma M
Clin Transl Oncol; 2020 Oct; 22(10):1667-1680. PubMed ID: 32170639
[TBL] [Abstract][Full Text] [Related]
4. Phase II drug metabolizing enzymes.
Jancova P; Anzenbacher P; Anzenbacherova E
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Jun; 154(2):103-16. PubMed ID: 20668491
[TBL] [Abstract][Full Text] [Related]
5. The role of genetic polymorphisms in metabolism of carcinogenic heterocyclic aromatic amines.
Turesky RJ
Curr Drug Metab; 2004 Apr; 5(2):169-80. PubMed ID: 15078194
[TBL] [Abstract][Full Text] [Related]
6. Role of phase II drug metabolizing enzymes in cancer chemoprevention.
Jana S; Mandlekar S
Curr Drug Metab; 2009 Jul; 10(6):595-616. PubMed ID: 19702535
[TBL] [Abstract][Full Text] [Related]
7. Drug metabolizing enzymes and their inhibitors' role in cancer resistance.
Pathania S; Bhatia R; Baldi A; Singh R; Rawal RK
Biomed Pharmacother; 2018 Sep; 105():53-65. PubMed ID: 29843045
[TBL] [Abstract][Full Text] [Related]
8. Inter-individual Variability in Activity of the Major Drug Metabolizing Enzymes in Liver Homogenates of 20 Individuals.
den Braver-Sewradj SP; den Braver MW; van Dijk M; Zhang Y; Dekker SJ; Wijaya L; Vermeulen NPE; Richert L; Commandeur JNM; Vos JC
Curr Drug Metab; 2018; 19(4):370-381. PubMed ID: 29318967
[TBL] [Abstract][Full Text] [Related]
9. Gene-environment interactions in esophageal cancer.
Matejcic M; Iqbal Parker M
Crit Rev Clin Lab Sci; 2015; 52(5):211-31. PubMed ID: 26220475
[TBL] [Abstract][Full Text] [Related]
10. Advances in the Understanding of Protein-Protein Interactions in Drug Metabolizing Enzymes through the Use of Biophysical Techniques.
Lampe JN
Front Pharmacol; 2017; 8():521. PubMed ID: 28848438
[TBL] [Abstract][Full Text] [Related]
11. Coordinated regulation of hepatic phase I and II drug-metabolizing genes and transporters using AhR-, CAR-, PXR-, PPARĪ±-, and Nrf2-null mice.
Aleksunes LM; Klaassen CD
Drug Metab Dispos; 2012 Jul; 40(7):1366-79. PubMed ID: 22496397
[TBL] [Abstract][Full Text] [Related]
12. Drug metabolism enzyme expression and activity in primary cultures of human proximal tubular cells.
Lash LH; Putt DA; Cai H
Toxicology; 2008 Feb; 244(1):56-65. PubMed ID: 18055091
[TBL] [Abstract][Full Text] [Related]
13. High-Throughput Assessment of Metabolism-Induced Toxicity of Compounds on a 384-Pillar Plate.
Kang SY; Yu KN; Joshi P; Lee MY
Methods Mol Biol; 2020; 2089():191-207. PubMed ID: 31773656
[TBL] [Abstract][Full Text] [Related]
14. Overview of enzymes of drug metabolism.
Meyer UA
J Pharmacokinet Biopharm; 1996 Oct; 24(5):449-59. PubMed ID: 9131484
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Differential Tissue Abundance of Major Non-CYP Enzymes in Human.
Basit A; Neradugomma NK; Wolford C; Fan PW; Murray B; Takahashi RH; Khojasteh SC; Smith BJ; Heyward S; Totah RA; Kelly EJ; Prasad B
Mol Pharm; 2020 Nov; 17(11):4114-4124. PubMed ID: 32955894
[TBL] [Abstract][Full Text] [Related]
16. [Human drug metabolizing enzymes. II. Conjugation enzymes].
Vereczkey L; Jemnitz K; Gregus Z
Acta Pharm Hung; 1998 Sep; 68(5):284-8. PubMed ID: 9805814
[TBL] [Abstract][Full Text] [Related]
17. Characterization of xenobiotic metabolizing enzymes of a reconstructed human epidermal model from adult hair follicles.
Bacqueville D; Jacques C; Duprat L; Jamin EL; Guiraud B; Perdu E; Bessou-Touya S; Zalko D; Duplan H
Toxicol Appl Pharmacol; 2017 Aug; 329():190-201. PubMed ID: 28601433
[TBL] [Abstract][Full Text] [Related]
18. Profiles and Gender-Specifics of UDP-Glucuronosyltransferases and Sulfotransferases Expressions in the Major Metabolic Organs of Wild-Type and Efflux Transporter Knockout FVB Mice.
Chen J; Zheng H; Zeng S; Xie C; Li X; Yan T; Gong X; Lu L; Qi X; Wang Y; Hu M; Zhu L; Liu Z
Mol Pharm; 2017 Sep; 14(9):2967-2976. PubMed ID: 28661152
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics of phase I and phase II drug metabolism.
Crettol S; Petrovic N; Murray M
Curr Pharm Des; 2010; 16(2):204-19. PubMed ID: 19835560
[TBL] [Abstract][Full Text] [Related]
20. PBPK Modelling for Drugs Cleared by Non-CYP Enzymes: State-of-the-Art and Future Perspectives.
Ozbey AC; Fowler S; Leys K; Annaert P; Umehara K; Parrott N
Drug Metab Dispos; 2023 Oct; ():. PubMed ID: 37879848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
